Summit Global Investments’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,180
Closed -$142K 629
2021
Q3
$142K Buy
+3,180
New +$142K 0.01% 452